Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Disease Progression × brigatinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 4 Neuroma, Acoustic 1 Neurofibromatosis 2 1 NSCLC 1 Meningioma 1 Lymphoma, Large-Cell, Anaplastic 1 Granuloma, Plasma Cell 1 Ependymoma 1 ALK-positive Advanced NSCLC 1 ALK+ Advanced NSCLC 1

Interventions

Cisplatin 3 capivasertib 2 Radiosurgery 2 Nivolumab 2 Carboplatin 2 tivozanib 1 pazopanib 1 niraparib 1 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 fludarabine 1 encorafenib 1 durvalumab 1 copanlisib 1 cemiplimab 1 axicabtagene ciloleucel 1 avasopasem manganese 1 abexinostat 1 Receptors, Interleukin-6 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Leucovorin 1 Interleukin 1 Receptor Antagonist Protein 1 Gemcitabine 1 Fulvestrant 1 Folfox protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡